(Q45760068)

15 December 2017

title

Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs (English)

1 reference

15 December 2017

0 references

1 reference

1

1 reference

15 December 2017

Stewart F. Owen

4

1 reference

15 December 2017

author name string

William S Redfern

2

1 reference

15 December 2017

Amanda J Hayfield

3

1 reference

15 December 2017

Jean-Pierre Valentin

5

1 reference

15 December 2017

Thomas H Hutchinson

6

1 reference

15 December 2017

publication date

9 February 2008

1 reference

15 December 2017

Journal of Pharmacological and Toxicological Methods

published in

1 reference

15 December 2017

volume

57

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

page(s)

176-187

1 reference

15 December 2017

A large-scale mutagenesis screen to identify seizure-resistant zebrafish

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Rat subicular networks gate hippocampal output activity in an in vitro model of limbic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

L-type calcium channels contribute to the tottering mouse dystonic episodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Bupropion: pharmacology and therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Zebrafish as a pharmacological tool: the how, why and when

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Epileptogenic effect of antibiotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Culturing of fathead minnow (Pimephales promelasL.) larvae for aquatic toxicity testing: An observational note

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Modulation of swimming in the lamprey, Petromyzon marinus, by serotonergic and dopaminergic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Zebrafish: a new model on the pharmaceutical catwalk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Strain-dependent effects of developmental ethanol exposure in zebrafish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Severe metabolic acidosis after acute naproxen sodium ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Contact and photocontact allergy to ketoprofen. The Belgian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

The anticonvulsant action of propofol on epileptiform activity in rat hippocampal slices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Zebrafish: a preclinical model for drug screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Cromakalim (BRL 34915) counteracts the epileptiform activity elicited by diltiazem and verapamil in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Bupropion: risks and benefits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Zebrafish assays for drug toxicity screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Epileptogenic drugs: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Endogenous dopaminergic modulation of the lamprey spinal locomotor network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

The use of zebrafish for assessing ototoxic and otoprotective agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Stability of benzylpenicillin during continuous home intravenous therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Several different ion channel modulators abrogate contact hypersensitivity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Effect of cefamandole nafate on the toxicity of tobramycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

Clinical features, pathogenesis and management of drug-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2008.01.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VASCN.2008.01.004

1 reference

15 December 2017

1 reference

15 December 2017